Clinical Trial: Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS

Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational

Official Title: Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS

Brief Summary: To observe the effect of goserelin 3,6mg sc depot injection by assessment of the mean percent reduction scores for symptoms: dysmenorrhoea, dyspareunia and pelvic pain; to observe the effect of goserelin 3,6mg sc depot injection by assessment of the mean percent reduction scores for pelvic tenderness and indurations; to observe the reduction in the proportion of patients requiring analgesics for the relief of pelvic pain for 6 months in patients treated with Zoladex 3.6 mg.

Detailed Summary:
Sponsor: AstraZeneca

Current Primary Outcome: Biberoglu and Bergham Scale [ Time Frame: monthly/ at every clinic visit- 6 times for symptoms: dysmenorrhoea, dyspareunia and pelvic pain ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Biberoglu and Bergham Scale [ Time Frame: twice/first and last clinic visit for pelvic tenderness and indurations ]

Original Secondary Outcome: Same as current

Information By: AstraZeneca

Dates:
Date Received: September 26, 2008
Date Started: October 2008
Date Completion:
Last Updated: September 8, 2009
Last Verified: September 2009